Clinical Material and Methods
With the approval of the Institutional Review Board of the Oregon Health & Science University, clinical records were selected for eight patients whose final diagnosis was non-AIDS-related PCNSL (in six) or MS (in two), but in whom the diagnosis was equivocal at initial presentation.
Case Reports

Case 1: PCNSL Presenting as MS
In this 55-year-old woman, a left hemiparesis developed acutely. Based on initial MR imaging findings, either PCNSL or MS seemed possible. The CSF analysis showed elevated levels of immunoglobulin G but no oligoclonal bands. The presumptive diagnosis was MS, and high doses of dexamethasone were given. Improvement was shortlived, and a repeated MR image demonstrated progression of the initial lesion (Fig. 1) . Results of a stereotactic biopsy procedure proved diffuse large B-cell lymphoma. The patient's condition improved remarkably with chemotherapy.
Case 2: PCNSL With Trigeminal Neuralgia
In this 49-year-old man, diplopia and right-sided trigeminal neuralgia in the V2 distribution developed subacutely. The MR imaging study revealed a discretely enlarged right cavernous sinus. The patient's condition was managed with corticosteroid agents because of a presumptive diagnosis of Tolosa-Hunt syndrome, and the treatment resulted in temporary relief. An MR imaging study obtained after symptom recurrence demonstrated an increase in the size of the lesion (Fig. 2) . A biopsy sample obtained in the cavernous sinus demonstrated inflammatory changes and necrotic large blue cells. Subsequently, focal-beam radiation (35 Gy) was administered to the cavernous sinus. One year later, a metastatic lesion in the foramina of C-6 was revealed to be PCNSL.
Case 3: Consequences of Preoperative Steroid Treatment in PCNSL
This 11-year-old boy with a left temporal lobe mass presented with abdominal pain, nausea, and tonic-clonic seizures (Fig. 3) . Due to significant perilesional edema, high doses of dexamethasone were administered before biopsy sampling was performed; biopsy results showed inflammatory changes only. Biopsy sampling of the lesion was performed via craniotomy 2 months later without corticosteroid premedication, and the final diagnosis was PCNSL.
Case 4: Unusual Presentation of MS Makes Tumor Likely Enough to Justify Biopsy Sampling
This healthy 45-year-old woman suffered a single tonic-clonic seizure. An MR image was obtained, and it revealed multiple enhancing white matter lesions ( Fig. 4A  and B) . Results of CSF analysis were normal. Before stereotactic biopsy sampling was performed, a second MR imaging study was obtained in which iron oxide nanoparticle contrast material was used ( Fig. 4C and D) . This study demonstrated less enhancement of the lesions compared with the previous gadolinium-enhanced study; these latest results favored MS. Analysis of biopsy samples demonstrated inflammatory changes and demyelination consistent with MS.
Case 5: Demyelinating Disease Simulating Neoplasm
In this 13-year-old girl, a right hemiparesis developed acutely. Left posterior thalamic enhancement was seen on MR imaging (Fig. 5 left) . Although results of CSF analysis were normal, a stereotactic needle biopsy revealed inflammatory changes and demyelination. The patient's con- dition improved with the use of steroids, but a relapse occurred later with similar MR imaging changes in the opposite thalamus (Fig. 5 right) and oligoclonal bands in the CSF, findings consistent with MS.
Case 6: The Importance of "Floaters" in PCNSL
This 63-year-old woman reported "floaters" and blurry vision. An enhancing area in the right cerebellum extending into the pons was demonstrated on MR imaging (Fig.  6 ). Further management of her condition included plans for an open biopsy procedure. However, a slit-lamp examination performed before surgery showed abnormalities, and a subsequent vitrectomy demonstrated diffuse large B-cell lymphoma. The diagnosis of PCNSL with ocular involvement was made, and a cerebellar biopsy procedure was avoided.
Case 7: Complete Resection Is not Indicated in PCNSL
This 60-year-old man with mild sensory deficits in his left hand underwent a gross-total resection of a right premotor cortex mass in which the presumptive diagnosis was glial tumor (Fig. 7 left) . However, pathological evaluation showed diffuse large B-cell lymphoma. The patient was temporarily hemiparetic after the procedure. A follow-up MR imaging study obtained 1 month postsurgery demonstrated recurrent tumor in the surgical cavity (Fig. 7  center) . The patient achieved complete remission after 1 year of high-dose methotrexate administered in conjunction with BBB disruption (Fig. 7 right) .
Case 8: The Risk Associated With Aggressive Resection in PCNSL
This 58-year-old woman underwent resection of a lesion that was presumed to be a corpus callosum glioma (Fig. 8 ). Pathological investigation revealed PCNSL. The patient experienced postoperative fevers and neurological decline after starting nonmyelosuppressive chemotherapy. A fungal infection at the surgical site was diagnosed. No further chemotherapy could be administered due to her poor performance status, and the patient died of progressive neurological decline.
Discussion
Non-AIDS-related PCNSL frequently presents with multiple enhancing lesions in the periventricular white matter and with signs and symptoms that are similar to many CNS diseases such as MS, metastases, malignant gliomas, and inflammatory diseases. The incidence is approximately 3.8 cases per million persons per year. 22 An unexplained threefold increase in the incidence of PCNSL has been observed in the past 30 years. 15 Primary central nervous system lymphoma is frequently diagnosed late because more common CNS diseases are considered first.
A PCNSL is a high-grade malignancy. Survival time is shorter in patients with coexisting ocular lymphoma, involvement of deep structures of the brain, meningeal disease, 18 low Karnofsky performance status (Ͻ 70), high CSF protein levels, elevated lactate dehydrogenase, age greater than 60 years, and at relapse. 5, 16, 21, 25 Early diagnosis can significantly affect the prognosis because PCNSL is highly chemo-and radiosensitive, and chemotherapy with or without radiation significantly improves the outcome. [28] [29] [30] 36 Survival time without treatment is very short. 
Cases 1, 4, and 5: PCNSL and MS-Importance of CSF Analysis Compared With Biopsy Procedures
Multiple sclerosis is a multifocal white matter disease. Together with a typical clinical history, a CSF analysis can help confirm the diagnosis. Unfortunately, the changes observed in the CSF, such as elevated levels of immunoglobulin G and oligoclonal bands, are nonspecific. Elevated immunoglobulin G (40-85% of patients) and oligoclonal bands (0-27%) can also be found in PCNSL. 8, 20 Elevated protein levels (> 80%) and increased cellularity (40%) are also common, although marked pleocytosis is rarely seen. All of these findings are also present in other inflammatory diseases of the CNS. If the clinical signs and symptoms, imaging studies, and CSF analysis are consistent with MS, treatment with steroid agents is normally the next step. Patients often improve after only one dose. However, patients with PCNSL also respond rapidly to steroid drugs, thus complicating the diagnosis, and perhaps delaying it until recurrence.
If PCNSL compared with MS is the differential diagnosis, a high-volume LP should be obtained, and in addition to conventional cytological studies, material should be reserved for flow cytometry and, if possible, polymerase chain reaction studies (Fig. 9) . 4, 14 Multiple CSF samples may be needed for establishment of the diagnosis. These additional LPs should be done as soon as possible to avoid delays in diagnosis. When there is leptomeningeal involvement, the LP site is important. 11 Patients with periventricular lesions have fewer false-negative findings when the puncture is done from an Ommaya reservoir or shunt (if available); conversely, in patients with spinal and/or radicular symptoms, an LP may be preferable. 9 In Cases 1, 4, and 5, the CSF analysis was either equivocal or normal; thus, biopsy sampling was the next logical step to confirm the diagnosis.
Cases 2 and 3: Importance of Avoiding Steroids Before Brain Biopsy, LP, and Slit-Lamp Examination/Vitrectomy
Diseases such as PCNSL, MS, other inflammatory disorders, and even gliomas may have similar, dramatic clinical and radiological responses to steroid agents. 9, 14, 41 A PCNSL may even disappear on imaging studies (the "ghost tumor" effect).
3,38,40 Steroid drugs should not be administered before diagnostic procedures are completed unless it is absolutely necessary (when PCNSL is in the differential diagnosis and the patient's condition will tolerate it). The patients in Cases 2 and 3 exemplify how the effect of steroid medications can render the pathological diagnosis impossible, thus delaying the diagnosis and necessitating a repeated biopsy procedure. A PCNSL can cause demyelination; therefore, biopsy tissue samples that are devoid of malignant B lymphocytes due to the effects of steroid drugs may be falsely interpreted as confirming a demyelinating disease. Furthermore, a PCNSL can present as T-cell-rich B-cell lymphoma, and in these cases, administration of steroid agents may lead to biopsy samples consisting of T cells and cells with demyelination only.
When cranial nerves are affected, a variety of skull base pathological entities should to be considered. Inflammatory processes tend to have a subacute onset and good response to steroid therapy. 20, 31, 32, 37 Because skull base procedures are complex and many are associated with higher complication rates compared with stereotactic needle biopsy, avoiding a biopsy procedure can be beneficial in a select subgroup of patients in whom CSF assessment and slit-lamp examination in the absence of steroid therapy yield the diagnosis (Fig. 9) .
Cases 4 and 5: MS can Mimic a Neoplasm, and new Imaging Techniques and/or Biopsy Sampling can be Useful in Differential Diagnosis
The patient in Case 4 presented with a single tonic-clonic seizure, which was suggestive of tumor rather than MS. The results of MR imaging also implicated PCNSL or metastatic disease (Fig. 4A and B) . FIG. 6. Case 6. Axial MR imaging studies obtained in a patient who had "floaters" for 2 years at first presentation. Left: An MR image demonstrating an enhancing lesion extending from the right cerebellar peduncle to the ipsilateral cerebellar hemisphere. On slit-lamp examination, ocular lymphoma was suspected, and the diagnosis was confirmed on vitrectomy. By performing a vitrectomy, a more invasive brain biopsy procedure could be avoided. Right: One year after chemotherapy, the patient is disease free and has an excellent performance status. (Fig. 2 center) . Analysis of stereotactic biopsy samples confirmed MS.
Although the prevalence of epilepsy in patients with MS is higher compared with the general population, seizures are rarely observed in MS. 10, 27, 34 An isolated seizure without neurological deficits is also unusual for PCNSL; rather, a progressive neurological decline over a period of months prior to diagnosis is common. 8, 21, 22 In this patient (Case 4), the clinical presentation was not typical for MS or PCNSL, and based on imaging findings, either diagnosis seemed possible. Therefore, diagnosis based on results of a biopsy procedure was the logical next step.
Similarly, the clinical presentation of the patient in Case 5 favored a tumor; a demyelinating process in this pediatric patient seemed less likely. Biopsy sampling revealed demyelination and inflammatory changes, and together with the relapsing-remitting clinical course and typical CSF findings, the diagnosis of MS was eventually established.
In 90% of PCNSL, a diffuse and dense gadolinium enhancement with varying degrees of perilesional edema is seen on MR imaging. Sixty percent of the patients have a single (typically periventricular) lesion. 23 Nevertheless, exceptions to this typical presentation have been reported. 17 Furthermore, patients with PCNSL can even present with normal findings on MR imaging. 25 The new modalities of MR spectroscopy and SPECT scanning have been used in the differential diagnosis of demyelination and tumor. 17 Both studies can be especially useful in the differential diagnosis of lesions located in areas of high risk for sequelae postsurgery. 32 Iron oxide nanoparticles are a new family of MR imaging contrast agents with a long plasma half-life that can be used to visualize inflammatory reactions in CNS lesions. They cross BBB defects and pool in the interstitial space, where they are phagocytosed by macrophages and reactive astrocytes. Lesions enhance when both a defective BBB and inflammation are present. When iron oxide nanoparticles are used, lymphomas and malignant gliomas tend to enhance more and MS tends to enhance less when compared with gadolinium studies, and thus, they may be useful in the differential diagnosis of malignant neoplasms versus MS, as demonstrated in the patient in Case 4. 26 Use of these particles, or other specialized MR imaging techniques such as MR spectroscopy or perfusion MR imaging, may provide additional information, but their effectiveness is still uncertain.
Case 6: Slit-Lamp Examination and Vitrectomy can Avoid Brain Biopsy Sampling
Ocular lymphoma is a manifestation of PCNSL that often presents with "floaters" or blurry vision. A slit-lamp examination is required in every patient suspected of having PCNSL, especially when these typical symptoms are noted. If results of the examination are abnormal, a vitrectomy, which is less invasive than brain biopsy sampling, is indicated (Fig. 9 ). In the patient in Case 6, the brain biopsy procedure was avoided because the diagnosis was established through vitrectomy.
Cases 7 and 8: Surgery in PCNSL Is for Diagnostic Purposes Only
The purpose of surgery in PCNSL is establishment of a
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Diagnostic dilemmas in primary central nervous system lymphoma diagnosis rather than cytoreduction. 8, 25 Because PCNSL can resemble glioma on imaging studies, the lesion is sometimes reached through a conventional craniotomy with the expectation of total or subtotal resection. Due to the more invasive nature of resection, the preliminary diagnosis based on the frozen tumor sections should be established before proceeding with surgery if the differential diagnosis includes PCNSL.
Conclusions
Demyelinating diseases, especially MS, are part of the most important differential diagnoses of PCNSL, although PCNSL can mimic many different intracranial pathological entities. Both PCNSL and MS are multifocal white matter lesions that can share the features of similar CSF findings 2, 12, 35, 39 and dramatic response to steroid drugs. 40 A systematic diagnostic approach reduces the possibility of confusing these two diseases and can improve outcomes through rapid establishment of the diagnosis. The LP procedure (high-volume and repeated if necessary) and slitlamp examination/vitrectomy are diagnostic procedures that can obviate the need for surgical biopsy sampling. Complete resection is not indicated and can lead to unnecessary and serious side effects.
New imaging techniques like SPECT scanning, MR spectroscopy, perfusion MR imaging, and iron nanoparticle imaging studies can help in the differential diagnosis of neoplastic compared with inflammatory lesions and should be further investigated. Corticosteroid drugs should be avoided before diagnostic procedures are completed, due to their cytolytic effects on malignant lymphocytes. 39 In patients treated preoperatively with steroid agents, if the tissue sample does not show tumor, multiple LPs and/ or a second biopsy procedure should be considered if there is clinical or radiological evidence of disease progression or recurrence. Early definitive diagnosis of PCNSL is the key; if it has not been established, patients who have MS may appropriately undergo brain biopsy sampling as part of their evaluation to rule out PCNSL when it is part of the differential diagnosis. FIG. 9 . Algorithm showing the proposed clinical assessment of patients in whom the diagnosis of PCNSL seems unclear according to the initial clinical and radiological presentation. If possible and indicated, the least invasive procedures, like slit-lamp examination, vitrectomy, and CSF sampling through an LP, should be done first. If these procedures do not yield the diagnosis within a reasonable period , biopsy sampling is the next logical step. Biopsy procedures should be repeated if the diagnosis is in doubt, although this may be preceded by repeated imaging and repeated LP. Corticosteroid drugs should be avoided before any diagnostic step is performed. New imaging techniques like iron nanoparticle MR imaging, MR spectroscopy, perfusion MR imaging, and SPECT scanning can also help determine the final diagnosis.
